Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Cell Biochem ; 115(6): 1063-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24123071

ABSTRACT

Reactive oxygen species (ROS) modulate a variety of intracellular events, but their role in osteoblast adhesion and spreading remains unclear. ROS is a very-known physiological modulators of Protein Tyrosine Phosphatases activities, mainly to low molecular weight protein tyrosine phosphatase (LMW-PTP) activity. As this biological mechanism is not clear in osteoblast adhesion, we decided to investigate ROS levels and phosphorylations of FAK and Src, identifying these proteins as potential substrates to LMW-PTP activity. Our results showed that during osteoblast adhesion/spreading (30 min and 2 h of seeding) the intracellular ROS content (hydrogen peroxide) is finely regulated by an effective anti-oxidant system [catalase and Superoxide Dismutase (SOD) activities were evaluated]. During the first 30 min of adhesion, there was an increase in ROS production and a concomitant increase in focal adhesion kinase (FAK) activity after its phosphorylation at Tyrosine 397 (Y397 ). Moreover, after 2 h there was a decrease in ROS content and FAK phosphorylation. There was no significant change in LMW-PTP expression at 30 min or 2 h. In order to validate our hypothesis that LMW-PTP is able to control FAK activity by modulating its phosphorylation status, we decided to overexpress and silence LMW-PTP in this context. Our results showed that FAK phosphorylation at Y397 was increased and decreased in osteoblasts with silenced or overexpressed LMW-PTP, respectively. Together, these data show that ROS modulate FAK phosphorylation by an indirect way, suggesting that a LMW-PTP/FAK supra-molecular complex is involved in transient responses during osteoblast adhesion and spreading.


Subject(s)
Osteoblasts/metabolism , Protein Tyrosine Phosphatases/metabolism , Proto-Oncogene Proteins/metabolism , Reactive Oxygen Species/metabolism , Animals , Catalase/metabolism , Cell Adhesion , Cell Line , Flow Cytometry , Focal Adhesion Kinase 1/metabolism , Hydrogen Peroxide/metabolism , Immunoblotting , Kinetics , Mice , Microscopy, Confocal , Osteoblasts/cytology , Phosphorylation , Protein Tyrosine Phosphatases/genetics , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins pp60(c-src)/metabolism , RNA Interference , Superoxide Dismutase/metabolism , Time Factors , Tyrosine/metabolism
2.
Mol Cell Biochem ; 322(1-2): 143-50, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18989628

ABSTRACT

The bone formation executed by osteoblasts represents an interesting research field both for basic and applied investigations. The goal of this work was to evaluate the molecular mechanisms involved during osteoblast differentiation in vitro. Accordingly, we demonstrated that, during the osteoblastic differentiation, TIMP-2 and RECK presented differential expressions, where RECK expression was downregulated from the 14th day in contrast with an increase in TIMP-2. Concomitantly, our results showed a temporal regulation of two major signaling cascades during osteoblast differentiation: proliferation cascades in which RECK, PI3 K, and GSK-3beta play a pivotal role and latter, differentiation cascades with participation of Ras, Rho, Rac-1, PKC alpha/beta, and TIMP-2. Furthermore, we observed that phosphorylation level of paxillin was downregulated while FAK(125) remained unchangeable, but active during extracellular matrix (ECM) remodeling. Concluding, our results provide evidences that RECK and TIMP-2 are involved in the control of ECM remodeling in distinct phases of osteoblast differentiation by modulating MMP activities and a multitude of signaling proteins governs these events.


Subject(s)
Cell Differentiation , Membrane Glycoproteins/metabolism , Osteoblasts/cytology , Tissue Inhibitor of Metalloproteinase-2/metabolism , 3T3 Cells , Animals , Ascorbic Acid/pharmacology , Cell Cycle , Cells, Cultured , Extracellular Matrix/metabolism , GPI-Linked Proteins , Mice , Osteoblasts/metabolism , Protein Kinase C/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 11/metabolism , Signal Transduction , rac1 GTP-Binding Protein/metabolism , rho GTP-Binding Proteins/metabolism
3.
BMC Cancer ; 8: 24, 2008 Jan 28.
Article in English | MEDLINE | ID: mdl-18226207

ABSTRACT

BACKGROUND: Patients with advanced cancer suffer from cachexia, which is characterised by a marked weight loss, and is invariably associated with the presence of tumoral and humoral factors which are mainly responsible for the depletion of fat stores and muscular tissue. METHODS: In this work, we used cytotoxicity and enzymatic assays and morphological analysis to examine the effects of a proteolysis-inducing factor (PIF)-like molecule purified from ascitic fluid of Walker tumour-bearing rats (WF), which has been suggested to be responsible for muscle atrophy, on cultured C2C12 muscle cells. RESULTS: WF decreased the viability of C2C12 myotubes, especially at concentrations of 20-25 mug.mL-1. There was an increase in the content of the pro-oxidant malondialdehyde, and a decrease in antioxidant enzyme activity. Myotubes protein synthesis decreased and protein degradation increased together with an enhanced in the chymotrypsin-like enzyme activity, a measure of functional proteasome activity, after treatment with WF. Morphological alterations such as cell retraction and the presence of numerous cells in suspension were observed, particularly at high WF concentrations. CONCLUSION: These results indicate that WF has similar effects to those of proteolysis-inducing factor, but is less potent than the latter. Further studies are required to determine the precise role of WF in this experimental model.


Subject(s)
Cachexia/etiology , Carcinoma 256, Walker/physiopathology , Muscle Fibers, Skeletal/cytology , Muscle Fibers, Skeletal/metabolism , Muscular Atrophy/metabolism , Muscular Atrophy/pathology , Neoplasms, Experimental/physiopathology , Proteoglycans/metabolism , Animals , Ascitic Fluid/chemistry , Cachexia/metabolism , Carcinoma 256, Walker/chemistry , Cell Survival , Cells, Cultured , Disease Models, Animal , Male , Mice , Myoblasts , Proteoglycans/isolation & purification , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL